Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company has a research  collaboration  with Stanford  University's Department  of  Bioengineering for cancer drug development. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

Vanguard Total Stock Mkt Idx Inv

Vanguard Institutional 500 Index Trust

Vanguard Health Care Inv

The Health Care Select Sector SPDR® ETF

Vanguard Institutional Index I

American Funds New Perspective A

Capital Group New Perspective Comp

American Funds Growth Fund of Amer A

Capital Group Growth Fnd of Amer Comp

Vanguard Dividend Appreciation ETF

Edgewood Growth Instl

Vanguard Wellington™ Inv

SPDR® S&P 500® ETF Trust

Fidelity 500 Index

iShares Core S&P 500 ETF

Vanguard Dividend Growth Inv

Vanguard Value Index Inv

T. Rowe Price Capital Appreciation

American Funds Washington Mutual A

Capital Group Wash Mutual Invtrs Comp

Vanguard Group Inc

BlackRock Inc

Bank of New York Mellon Corp

T. Rowe Price Investment Management,Inc.

Franklin Resources Inc

Northern Trust Corp

Bank of America Corp

Edgewood Management LLC

Legal & General Group PLC

Goldman Sachs Group Inc

JPMorgan Chase & Co

Capital Research Global Investors

State Street Corp

FMR Inc

Wellington Management Company LLP

T. Rowe Price Associates, Inc.

Capital Research & Mgmt Co - Division 3

Geode Capital Management, LLC

Morgan Stanley - Brokerage Accounts

NORGES BANK

Danaher Corporation

Mr. Steven M. Rales

Co-Founder & Chairman

Mr. Rainer M. Blair

President, CEO & Director

Mr. Mitchell P. Rales

Co-Founder & Director

Mr. Matthew R. McGrew

CFO & Executive VP

Dr. Jose-Carlos  Gutierrez-Ramos Ph.D.

Senior VP & Chief Science Officer

Ms. Georgeann F. Couchara

Senior Vice President of Human Resources

Mr. Christopher M. Bouda

VP & Chief Accounting Officer

Mr. John  Bedford

Vice President of Investor Relations

Mr. Brian W. Ellis J.D.

Senior VP, General Counsel & Chief Compliance Officer

Mr. Daniel A. Raskas J.D.

Senior Vice President of Corporate Development

DHR's next earnings is on January 28, 2025 (Before Market Open)

DHR's latest dividend is 0.27 USD on June 28, 2024

Danaher Corporation (DHR) Stock Analysis, Discussion Forum and Financial Metrics - NYSE Exchange

Danaher Corporation (DHR) Earnings Report Date and History | NYSE

DHR's next earnings is on January 28, 2025 (Before Market Open)

When is the earnings report for DHR?

DHR Earnings History

DHR's latest dividend is 0.27 USD on June 28, 2024

DHR Stock Discussion Forum and Message Board

News for NYSE: DHR